| Literature DB >> 29030428 |
Kelly A Manthei1, Joomi Ahn2, Alisa Glukhova1, Wenmin Yuan3, Christopher Larkin2, Taylor D Manett1, Louise Chang1, James A Shayman4, Milton J Axley2, Anna Schwendeman3, John J G Tesmer5.
Abstract
Lecithin:cholesterol acyltransferase (LCAT) plays a key role in reverse cholesterol transport by transferring an acyl group from phosphatidylcholine to cholesterol, promoting the maturation of high-density lipoproteins (HDL) from discoidal to spherical particles. LCAT is activated through an unknown mechanism by apolipoprotein A-I (apoA-I) and other mimetic peptides that form a belt around HDL. Here, we report the crystal structure of LCAT with an extended lid that blocks access to the active site, consistent with an inactive conformation. Residues Thr-123 and Phe-382 in the catalytic domain form a latch-like interaction with hydrophobic residues in the lid. Because these residues are mutated in genetic disease, lid displacement was hypothesized to be an important feature of apoA-I activation. Functional studies of site-directed mutants revealed that loss of latch interactions or the entire lid enhanced activity against soluble ester substrates, and hydrogen-deuterium exchange (HDX) mass spectrometry revealed that the LCAT lid is extremely dynamic in solution. Upon addition of a covalent inhibitor that mimics one of the reaction intermediates, there is an overall decrease in HDX in the lid and adjacent regions of the protein, consistent with ordering. These data suggest a model wherein the active site of LCAT is shielded from soluble substrates by a dynamic lid until it interacts with HDL to allow transesterification to proceed.Entities:
Keywords: HDX MS; acyltransferase; apolipoprotein; cholesterol; conformational change; crystallography; high-density lipoprotein (HDL); inhibitor; lecithin; structural biology
Mesh:
Substances:
Year: 2017 PMID: 29030428 PMCID: PMC5724016 DOI: 10.1074/jbc.M117.802736
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157